PMC:7242013 / 5506-6065 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"181","span":{"begin":67,"end":75},"obj":"Species"},{"id":"182","span":{"begin":128,"end":136},"obj":"Species"},{"id":"183","span":{"begin":211,"end":219},"obj":"Species"},{"id":"184","span":{"begin":295,"end":303},"obj":"Species"},{"id":"185","span":{"begin":356,"end":364},"obj":"Species"},{"id":"186","span":{"begin":439,"end":447},"obj":"Species"},{"id":"187","span":{"begin":513,"end":520},"obj":"Species"},{"id":"223","span":{"begin":7,"end":45},"obj":"Disease"},{"id":"224","span":{"begin":81,"end":86},"obj":"Disease"},{"id":"225","span":{"begin":145,"end":153},"obj":"Disease"},{"id":"226","span":{"begin":225,"end":233},"obj":"Disease"},{"id":"227","span":{"begin":309,"end":314},"obj":"Disease"},{"id":"228","span":{"begin":373,"end":381},"obj":"Disease"},{"id":"229","span":{"begin":453,"end":461},"obj":"Disease"}],"attributes":[{"id":"A181","pred":"tao:has_database_id","subj":"181","obj":"Tax:9606"},{"id":"A182","pred":"tao:has_database_id","subj":"182","obj":"Tax:9606"},{"id":"A183","pred":"tao:has_database_id","subj":"183","obj":"Tax:9606"},{"id":"A184","pred":"tao:has_database_id","subj":"184","obj":"Tax:9606"},{"id":"A185","pred":"tao:has_database_id","subj":"185","obj":"Tax:9606"},{"id":"A186","pred":"tao:has_database_id","subj":"186","obj":"Tax:9606"},{"id":"A187","pred":"tao:has_database_id","subj":"187","obj":"Tax:9606"},{"id":"A223","pred":"tao:has_database_id","subj":"223","obj":"MESH:D006509"},{"id":"A224","pred":"tao:has_database_id","subj":"224","obj":"MESH:C000657245"},{"id":"A225","pred":"tao:has_database_id","subj":"225","obj":"MESH:C000657245"},{"id":"A226","pred":"tao:has_database_id","subj":"226","obj":"MESH:C000657245"},{"id":"A227","pred":"tao:has_database_id","subj":"227","obj":"MESH:C000657245"},{"id":"A228","pred":"tao:has_database_id","subj":"228","obj":"MESH:C000657245"},{"id":"A229","pred":"tao:has_database_id","subj":"229","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Manage hepatitis B; hepatitis C Continue HBV and HCV treatment of patients with COVID‐19\nProceed with HBV and HCV treatment in patients without COVID‐19 as clinically warranted\nDo not consider HBV treatment in patients with COVID‐19 unless flare is suspected Continue HBV and HCV treatment of patients with COVID‐19\nProceed with HBV and HCV treatment in patients without COVID‐19 as clinically warranted\nDo not consider HBV treatment in patients with COVID‐19 unless flare is suspected\nDocument discussion with patient regarding CLD diagnosis and management"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T75","span":{"begin":7,"end":18},"obj":"Disease"},{"id":"T76","span":{"begin":7,"end":16},"obj":"Disease"},{"id":"T77","span":{"begin":20,"end":31},"obj":"Disease"},{"id":"T78","span":{"begin":20,"end":29},"obj":"Disease"},{"id":"T79","span":{"begin":81,"end":89},"obj":"Disease"},{"id":"T80","span":{"begin":145,"end":153},"obj":"Disease"},{"id":"T81","span":{"begin":225,"end":233},"obj":"Disease"},{"id":"T82","span":{"begin":309,"end":317},"obj":"Disease"},{"id":"T83","span":{"begin":373,"end":381},"obj":"Disease"},{"id":"T84","span":{"begin":453,"end":461},"obj":"Disease"},{"id":"T85","span":{"begin":531,"end":534},"obj":"Disease"}],"attributes":[{"id":"A75","pred":"mondo_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/MONDO_0005344"},{"id":"A76","pred":"mondo_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"},{"id":"A77","pred":"mondo_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/MONDO_0005231"},{"id":"A78","pred":"mondo_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"},{"id":"A79","pred":"mondo_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A80","pred":"mondo_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A81","pred":"mondo_id","subj":"T81","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A82","pred":"mondo_id","subj":"T82","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A83","pred":"mondo_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A84","pred":"mondo_id","subj":"T84","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A85","pred":"mondo_id","subj":"T85","obj":"http://purl.obolibrary.org/obo/MONDO_0008964"}],"text":"Manage hepatitis B; hepatitis C Continue HBV and HCV treatment of patients with COVID‐19\nProceed with HBV and HCV treatment in patients without COVID‐19 as clinically warranted\nDo not consider HBV treatment in patients with COVID‐19 unless flare is suspected Continue HBV and HCV treatment of patients with COVID‐19\nProceed with HBV and HCV treatment in patients without COVID‐19 as clinically warranted\nDo not consider HBV treatment in patients with COVID‐19 unless flare is suspected\nDocument discussion with patient regarding CLD diagnosis and management"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T60","span":{"begin":17,"end":18},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"}],"text":"Manage hepatitis B; hepatitis C Continue HBV and HCV treatment of patients with COVID‐19\nProceed with HBV and HCV treatment in patients without COVID‐19 as clinically warranted\nDo not consider HBV treatment in patients with COVID‐19 unless flare is suspected Continue HBV and HCV treatment of patients with COVID‐19\nProceed with HBV and HCV treatment in patients without COVID‐19 as clinically warranted\nDo not consider HBV treatment in patients with COVID‐19 unless flare is suspected\nDocument discussion with patient regarding CLD diagnosis and management"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T26","span":{"begin":0,"end":6},"obj":"Chemical"}],"attributes":[{"id":"A26","pred":"chebi_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/CHEBI_81767"}],"text":"Manage hepatitis B; hepatitis C Continue HBV and HCV treatment of patients with COVID‐19\nProceed with HBV and HCV treatment in patients without COVID‐19 as clinically warranted\nDo not consider HBV treatment in patients with COVID‐19 unless flare is suspected Continue HBV and HCV treatment of patients with COVID‐19\nProceed with HBV and HCV treatment in patients without COVID‐19 as clinically warranted\nDo not consider HBV treatment in patients with COVID‐19 unless flare is suspected\nDocument discussion with patient regarding CLD diagnosis and management"}

{"project":"LitCovid-sentences","denotations":[{"id":"T74","span":{"begin":0,"end":89},"obj":"Sentence"},{"id":"T75","span":{"begin":90,"end":177},"obj":"Sentence"},{"id":"T76","span":{"begin":178,"end":317},"obj":"Sentence"},{"id":"T77","span":{"begin":318,"end":405},"obj":"Sentence"},{"id":"T78","span":{"begin":406,"end":487},"obj":"Sentence"},{"id":"T79","span":{"begin":488,"end":559},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Manage hepatitis B; hepatitis C Continue HBV and HCV treatment of patients with COVID‐19\nProceed with HBV and HCV treatment in patients without COVID‐19 as clinically warranted\nDo not consider HBV treatment in patients with COVID‐19 unless flare is suspected Continue HBV and HCV treatment of patients with COVID‐19\nProceed with HBV and HCV treatment in patients without COVID‐19 as clinically warranted\nDo not consider HBV treatment in patients with COVID‐19 unless flare is suspected\nDocument discussion with patient regarding CLD diagnosis and management"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T18","span":{"begin":7,"end":16},"obj":"Phenotype"},{"id":"T19","span":{"begin":20,"end":29},"obj":"Phenotype"}],"attributes":[{"id":"A18","pred":"hp_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/HP_0012115"},{"id":"A19","pred":"hp_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/HP_0012115"}],"text":"Manage hepatitis B; hepatitis C Continue HBV and HCV treatment of patients with COVID‐19\nProceed with HBV and HCV treatment in patients without COVID‐19 as clinically warranted\nDo not consider HBV treatment in patients with COVID‐19 unless flare is suspected Continue HBV and HCV treatment of patients with COVID‐19\nProceed with HBV and HCV treatment in patients without COVID‐19 as clinically warranted\nDo not consider HBV treatment in patients with COVID‐19 unless flare is suspected\nDocument discussion with patient regarding CLD diagnosis and management"}